Vallabh Janardhan: Thrombectomy Has Transformed What Is Possible for Patients with Life-Threatening Vascular Emergencies
Vallabh Janardhan, Co-Founder and CMO at Insera Therapeutics, Inc., shared on LinkedIn:
”Today is World Thrombectomy Day.
Thrombectomy refers to minimally invasive catheter-based procedures designed to remove blood clots from blood vessels and restore blood flow.
Over the last decade, thrombectomy has transformed what is possible for patients suffering from stroke and other life-threatening vascular emergencies including pulmonary embolism, deep vein thrombosis, acute limb ischemia, thrombosed dialysis access, and even certain forms of heart attack.
What once often resulted in devastating disability, limb loss, or death can now, in many cases, be treated through rapid image-guided intervention with remarkable recovery.
But successful thrombectomy begins long before the angio suite.
It begins with:
- awareness
- rapid recognition
- EMS activation
- transport coordination
- imaging
- emergency teams
- nurses, technologists, physicians, and multidisciplinary systems all moving together against time
One of the greatest privileges of my career has been working alongside extraordinary teams committed to advancing systems of care and improving access to life-saving intervention.
Breakthrough technology only changes outcomes when combined with great teams and coordinated systems of care.
Grateful to all the EMS professionals, nurses, physicians, technologists, hospital administrators, researchers, healthcare and medtech investors, innovators, professional societies, industry partners, healthcare systems, patients, and families advancing thrombectomy care around the world every single day.”
Stay updated with Hemostasis Today.
-
May 15, 2026, 07:27Maria Kuzmina: How Chronic Inflammation Affects Extramedullary Hematopoiesis
-
May 15, 2026, 04:34Aryabhatta Sadhu: Honoured to Speak at The 5th European Congress on Hematology and Blood Disorders
-
May 15, 2026, 04:28Ashkan Shoamanesh: Thrilled to Be Leading The Global INTERCEPT Trial
-
May 15, 2026, 04:00Danny Hsu: Join The THANZ Webinar on The Art and Science of Anticoagulation Stewardship
-
May 15, 2026, 03:48Deepak Yadav: What If the Way We Classify Stroke Tissue Is Too Simplistic for Modern Stroke Care?
-
May 15, 2026, 03:32Damon Race: Can Gene Therapy Deliver Durable Expression Over Time?
-
May 14, 2026, 17:17Abhijit D: Reticulocyte Count Methods in Hematology Laboratories
-
May 14, 2026, 16:46Michele Romoli: Neurointerventional Workforce Gaps and Stroke Thrombectomy Access in Europe
-
May 14, 2026, 16:37Reyes Calzada Bau: What It Means to Live with Immune Thrombocytopenia